{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:58:46Z","timestamp":1762459126888},"reference-count":54,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["psyn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research: Neuroimaging"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.pscychresns.2013.10.002","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T10:14:40Z","timestamp":1382523280000},"page":"6-12","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication"],"prefix":"10.1016","volume":"221","author":[{"given":"Nathan L.","family":"Hutcheson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Bolding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne C.","family":"Lahti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pscychresns.2013.10.002_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs","volume":"67","author":"Andreasen","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1600-0447.1990.tb03070.x","article-title":"Predicting neuroleptic response from a combination of multilevel variables in acute schizophrenic patients","volume":"82","author":"Bartk\u00f3","year":"1990","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0006-8993(85)90532-3","article-title":"The effects of haloperidol on synaptic patterns in the rat striatum","volume":"329","author":"Benes","year":"1985","journal-title":"Brain Research"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.schres.2010.12.020","article-title":"Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis","volume":"127","author":"Bora","year":"2011","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/archpsyc.1992.01820120009003","article-title":"Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures","volume":"49","author":"Breier","year":"1992","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0920-9964(02)00526-1","article-title":"Caudate and putamen volumes in good and poor outcome patients with schizophrenia","volume":"64","author":"Buchsbaum","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib7","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1176\/ajp.151.10.1430","article-title":"Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs","volume":"151","author":"Chakos","year":"1994","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(95)90441-7","article-title":"Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine","volume":"345","author":"Chakos","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/schbul\/sbp073","article-title":"Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression","volume":"37","author":"Chan","year":"2011","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1017\/S0033291708004212","article-title":"Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment","volume":"39","author":"Chua","year":"2009","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/schbul\/23.4.663","article-title":"Evaluation of treatment-resistant schizophrenia","volume":"23","author":"Conley","year":"1997","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jpsychires.2006.05.002","article-title":"Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables","volume":"41","author":"Crespo-Facorro","year":"2007","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0278-5846(94)90026-4","article-title":"Schizophrenic syndromes associated with treatment response","volume":"18","author":"Cuesta","year":"1994","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/138161212799316253","article-title":"Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies","volume":"18","author":"De Peri","year":"2012","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1503\/jpn.090049","article-title":"Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia","volume":"35","author":"Ebdrup","year":"2010","journal-title":"Journal of Psychiatry and Neuroscience"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib16","first-page":"438","article-title":"Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review","volume":"20","author":"Ebdrup","year":"2013","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S1461145710000817","article-title":"Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms","volume":"14","author":"Ebdrup","year":"2011","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1176\/appi.ajp.2008.07101562","article-title":"The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis","volume":"165","author":"Ellison-Wright","year":"2008","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.schres.2008.12.011","article-title":"Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies","volume":"108","author":"Fornito","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/schbul\/sbr134","article-title":"Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM Studies","volume":"38","author":"Fusar-Poli","year":"2012","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib21","doi-asserted-by":"crossref","first-page":"e49732","DOI":"10.1371\/journal.pone.0049732","article-title":"Blinded prospective evaluation of computer-based mechanistic schizophrenia disease model for predicting drug response","volume":"7","author":"Geerts","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3371\/CSRP.GHFA.01062013","article-title":"Combination of estrogen and antipsychotics in the treatment of women with chronic schizophrenia","volume":"6","author":"Ghafari","year":"2013","journal-title":"Clinical Schizophrenia & Related Psychoses"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.biopsych.2008.03.031","article-title":"Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis","volume":"64","author":"Glahn","year":"2008","journal-title":"Biological Psychiatry"},{"issue":"5","key":"10.1016\/j.pscychresns.2013.10.002_bib24","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/schbul\/sbs118","article-title":"Brain volumes in schizophrenia: a meta-analysis in over 18,000 subjects","volume":"39","author":"Haijma","year":"2012","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib25","first-page":"1","article-title":"Schizophrenia manifestations, incidence and course in different cultures. A World Health Organization ten-country study","volume":"22","author":"Jablensky","year":"1992","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib26","first-page":"466","article-title":"Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders","volume":"56","author":"Keck","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00002826-199212000-00006","article-title":"Synaptic plasticity in the rat striatum following chronic haloperidol treatment","volume":"15","author":"Kerns","year":"1992","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib28","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(94)90599-1","article-title":"Changes in caudate volume with neuroleptic treatment","volume":"344","author":"Keshavan","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib29","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1523\/JNEUROSCI.1120-05.2005","article-title":"Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs","volume":"25","author":"Kippin","year":"2005","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0006-3223(01)01267-7","article-title":"Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia","volume":"50","author":"Konradi","year":"2001","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/schbul\/sbp099","article-title":"Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting","volume":"37","author":"Leung","year":"2011","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib32","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1017\/S0033291711002157","article-title":"Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment","volume":"42","author":"Li","year":"2011","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib33","first-page":"97","article-title":"Predictors of therapeutic response to haloperidol in acute schizophrenia","volume":"27","author":"McEvoy","year":"1991","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0006-8993(89)90867-6","article-title":"Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment","volume":"489","author":"Meshul","year":"1989","journal-title":"Brain Research"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pscychresns.2010.06.006","article-title":"Subcortical and cortical gray matter differences between Kraepelinian and non-Kraepelinian schizophrenia patients identified using voxel-based morphometry","volume":"184","author":"Molina","year":"2010","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00406-010-0182-2","article-title":"Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics","volume":"261","author":"Molina","year":"2011","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0925-4927(03)00107-0","article-title":"Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia","volume":"124","author":"Molina","year":"2003","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib38","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1017\/S0033291709005315","article-title":"Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings","volume":"39","author":"Navari","year":"2009","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archpsyc.1994.03950110009002","article-title":"Diagnostic Interview for Genetic Studies: rationale, unique features, and training","volume":"51","author":"Nurnberger","year":"1994","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000103575","article-title":"Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia","volume":"55","author":"Okugawa","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biopsych.2011.01.032","article-title":"Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies","volume":"70","author":"Olabi","year":"2011","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib42","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jalz.2010.05.1622","article-title":"The repeatable battery for the assessment of neuropsychological status (RBANS): utility as an outcome measure in clinical trials for MCI and mild dementia","volume":"6","author":"Randolph","year":"2010","journal-title":"Alzheimer\u2019s & Dementia: the Journal of the Alzheimer\u2019s Association"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/syn.890120208","article-title":"Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats","volume":"12","author":"See","year":"1992","journal-title":"Synapse"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib45","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1176\/ajp.154.12.1641","article-title":"Psychopathology in women and men: focus on female hormones","volume":"154","author":"Seeman","year":"1997","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib46","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.188.6.510","article-title":"Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies","volume":"188","author":"Steen","year":"2006","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib47","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archgenpsychiatry.2010.78","article-title":"Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease","volume":"67","author":"Thambisetty","year":"2010","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/syn.890070402","article-title":"Morphometric study of synaptic patterns in the rat caudate nucleus and hippocampus under haloperidol treatment","volume":"7","author":"Uranova","year":"1991","journal-title":"Synapse"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.schres.2008.09.009","article-title":"A systematic method for estimating individual responses to treatment with antipsychotics in CATIE","volume":"107","author":"van den Oord","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib161","doi-asserted-by":"crossref","unstructured":"Vita, A., De Peri, L., Deste, G., Sacchetti, E., 2012. Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Translational Psychiatry 2,1\u201313.","DOI":"10.1038\/tp.2012.116"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib51","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/sj.npp.1300449","article-title":"Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat","volume":"29","author":"Wang","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuroimage.2012.04.056","article-title":"Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion","volume":"62","author":"Westman","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib53","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.neuroimage.2009.12.028","article-title":"Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies","volume":"53","author":"Winkler","year":"2010","journal-title":"NeuroImage"},{"key":"10.1016\/j.pscychresns.2013.10.002_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.schres.2004.05.014","article-title":"Meta-analysis of the time-course of brain volume reduction in schizophrenia: implications for pathogenesis and early treatment","volume":"73","author":"Woods","year":"2005","journal-title":"Schizophrenia Research"}],"container-title":["Psychiatry Research: Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492713002734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492713002734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T05:33:29Z","timestamp":1564551209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925492713002734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0925492713002734"],"URL":"https:\/\/doi.org\/10.1016\/j.pscychresns.2013.10.002","relation":{},"ISSN":["0925-4927"],"issn-type":[{"value":"0925-4927","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research: Neuroimaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pscychresns.2013.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}